PMS-SUMATRIPTAN: may not contain the correct amount of tablets (empty blister packs)
Brand(s)
Last updated
Summary
Product
PMS-SUMATRIPTAN
Issue
Health products - Product quality
What to do
Consult your health care professional if you have any health concerns.
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot |
|---|---|---|---|---|---|
| PMS-SUMATRIPTAN | PMS-SUMATRIPTAN | DIN 02256436 | Tablet | Sumatriptan 50mg | 74934 |
Issue
Affected lot may not contain the correct amount of tablets (empty blister packs).
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Pharmascience Inc.
100-6111 Royalmount Ave,
Montreal, QC,
Canada
H4P 2T4
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-78000
Get notified
Receive notifications for new and updated recalls and alerts by category.